Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice

Experimental Eye Research

Volumn 88, Issue 6, 2009, Pages 1014-1019

  Steinle, Jena J ^a   Kern, Timothy S ^c   Thomas, Steven A ^d   McFadyen Ketchum, Lisa S ^b   Smith, Christopher P ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

basement membrane; diabetic retinopathy; norepinephrine; pericyte

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; NORADRENALIN;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL LOSS; CONTROLLED STUDY; DIABETIC RETINOPATHY; ELECTRON MICROSCOPY; FEMALE; KNOCKOUT MOUSE; MALE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RETINA CAPILLARY; RETINA GANGLION CELL; THICKNESS;

ANIMALS; BASEMENT MEMBRANE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DOPAMINE BETA-HYDROXYLASE; MICE; MICE, KNOCKOUT; PERICYTES; RETINA; RETINAL GANGLION CELLS; RETINAL VESSELS;

EID: 67349236222     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.12.015     Document Type: Article

References (35)

1. Barber A.J. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 283-290
2. Barber A.J., Lieth E., Khin S.A., Antonetti D.A., Buchanan A.G., and Gardner T.W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest. 102 (1998) 783-791
3. Burnstock G. Changes in expression of autonomic nerves in aging and disease. J. Auton. Nerv. Syst. 30 Suppl. (1990) S25-S34
4. Chen Z., Jia W., Kaufman P.L., and Cynader M. Immunohistochemical localization of dopamine-beta-hydroxylase in human and monkey eyes. Curr. Eye Res. 18 (1999) 39-48
5. Engerman R.L., and Kern T.S. Retinopathy in animal models of diabetes. Diabetes Metab. Rev. 11 (1995) 109-120
6. Feit-Leichman R.A., Kinouchi R., Takeda M., Fan Z., Mohr S., Kern T.S., and Chen D.F. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4281-4287
7. Furukawa H. Autonomic innervation of preretinal blood vessels of the rabbit. Invest. Ophthalmol. Vis. Sci. 28 (1987) 1752-1760
8. Gross, R.L., Hensley, S.H., Gao, F. Wu, S.M., 1999. Retinal ganglion cell dysfunction induced by hypoxia and glutamate:potential neuroprotective effects of beta-blockers. Surv. Ophthalmol. 43 Suppl:S162-170.
9. Hammes H.P., Lin J., Wagner P., Feng Y., Vom Hagen F., Krzizok T., Renner O., Breier G., Brownlee M., and Deutsch U. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 53 (2004) 1104-1110
10. Kawabe J., Aizawa Y., Takehara N., Hasebe N., and Kikuchi K. Glucose modifies the cross-talk between insulin and the beta-adrenergic signalling system in vascular smooth muscle cells. J. Hypertens. 18 (2000) 1457-1464
11. Kern T.S., and Engerman R.L. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Curr. Eye Res. 13 (1994) 863-867
12. Kowluru R.A., Tang J., and Kern T.S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50 (2001) 1938-1942
13. Lai R.K., Chun T., Hasson D., Lee S., Mehrbod F., and Wheeler L. Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat. Vis. Neurosci. 19 (2002) 175-185
14. Laties A.M., and Jacobowitz D. A comparative study of the autonomic innervation of the eye in monkey, cat, and rabbit. Anat. Rec. 156 (1966) 383-395
15. Mizutani M., Kern T.S., and Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin. Invest. 97 (1996) 2883-2890
16. Park D.H., Joh T.H., Anwar M., and Ruggiero D.A. Biochemical evidence for presence of dopamine beta-hydroxylase in rat retina. Brain Res. 460 (1988) 352-355
17. Pojda S.M., and Brus R. The effect of central chemical sympathectomy on the oxygen uptake; anaerobic glycolysis and lactic acid dehydrogenase activity in the retina of white rats. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 200 (1976) 223-226
18. Rieder C.L., Rupp G., and Bowser S.S. Electron microscopy of semi-thick sections: advantages for biomedical research. J. Electron Microsc. Tech. 2 (1985) 11-28
19. Schmidt R.E. Neuropathology and pathogenesis of diabetic autonomic neuropathy. Int. Rev. Neurobiol. 50 (2002) 257-292
20. Schmidt R.E., Chae H.Y., Parvin C.A., and Roth K.A. Neuroaxonal dystrophy in aging human sympathetic ganglia. Am. J. Pathol. 136 (1990) 1327-1338
21. Schmidt R.E., Beaudet L.N., Plurad S.B., and Dorsey D.A. Axonal cytoskeletal pathology in aged and diabetic human sympathetic autonomic ganglia. Brain Res. 769 (1997) 375-383
22. Steinle J.J. Sympathetic neurotransmission modulates expression of inflammatory markers in the rat retina. Exp. Eye Res. 84 (2007) 118-125
23. Steinle J.J., and Smith P.G. Role of adrenergic receptors in vascular remodelling of the rat choroid. Br. J. Pharmacol. 136 (2002) 730-734
24. Steinle J.J., Lindsay N.L., and Lashbrook B.L. Cervical sympathectomy causes photoreceptor-specific cell death in the rat retina. Auton. Neurosci. 120 (2005) 46-51
25. Tatton W., Chen D., Chalmers-Redman R., Wheeler L., Nixon R., and Tatton N. Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation. Surv. Ophthalmol. 48 Suppl. 1 (2003) S25-S37
26. Thomas S.A., Marck B.T., Palmiter R.D., and Matsumoto A.M. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J. Neurochem. 70 (1998) 2468-2476
27. Walker R., and Steinle J. Role of beta-adrenergic receptors in inflammatory marker expression in Muller cells. Invest. Ophthalmol. Vis. Sci. 48 (2007) 5276-5281
28. Wiley L.A., Rupp G.R., and Steinle J.J. Sympathetic innervation regulates basement membrane thickening and pericyte number in rat retina. Invest. Ophthalmol. Vis. Sci. 46 (2005) 744-748
29. Wiley L.A., Berkowitz B.A., and Steinle J.J. Superior cervical ganglionectomy induces changes in growth factor expression in the rat retina. Invest. Ophthalmol. Vis. Sci. 47 (2006) 439-443
30. Williamson J.R., Vogler N.J., and Kilo C. Estimation of vascular basement membrane thickness. Theoretical and practical considerations. Diabetes 18 (1969) 567-578
31. Williamson J.R., Vogler N.J., and Kilo C. Regional variations in the width of the basement membrane of muscle capillaries in man and giraffe. Am. J. Pathol. 63 (1971) 359-370
32. Witkovsky P., Alones V., and Piccolino M. Morphological changes induced in turtle retinal neurons by exposure to 6-hydroxydopamine and 5,6-dihydroxytryptamine. J. Neurocytol. 16 (1987) 55-67
33. Wood J.P., Schmidt K.G., Melena J., Chidlow G., Allmeier H., and Osborne N.N. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp. Eye Res. 76 (2003) 505-516
34. Zheng L., Howell S.J., Hatala D.A., Huang K., and Kern T.S. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 56 (2007) 337-345
35. Zheng Z., Chen H., Xu X., Li C., and Gu Q. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy. Exp. Eye Res. 84 (2007) 745-752